(CTN News) – In March, the Supreme Court will hear a case involving mifepristone, one of two medicines used in medication abortion. A significant question in that case is whether the Food and Medicine Administration was accurate when it determined that the medicine was safe to prescribe to patients via virtual appointment. Research published Thursday […]
Go to Source
Author: Arsi Mughal